NAM
NorthCrest Asset Manangement’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Sell |
53,817
-68
| -0.1% | -$29.2K | 0.62% | 43 |
|
|
2025
Q1 | $26.8M | Buy |
53,885
+1,354
| +3% | +$674K | 0.81% | 32 |
|
|
2024
Q4 | $27.3M | Buy |
52,531
+474
| +0.9% | +$247K | 0.82% | 27 |
|
|
2024
Q3 | $32.2M | Buy |
52,057
+899
| +2% | +$556K | 0.97% | 21 |
|
|
2024
Q2 | $28.3M | Buy |
51,158
+832
| +2% | +$460K | 0.94% | 22 |
|
|
2024
Q1 | $29.2M | Buy |
50,326
+480
| +1% | +$279K | 1% | 20 |
|
|
2023
Q4 | $26.5M | Sell |
49,846
-2,495
| -5% | -$1.32M | 1% | 19 |
|
|
2023
Q3 | $26.5M | Sell |
52,341
-240
| -0.5% | -$121K | 1.08% | 17 |
|
|
2023
Q2 | $27.4M | Sell |
52,581
-242
| -0.5% | -$126K | 1.09% | 17 |
|
|
2023
Q1 | $30.4M | Sell |
52,823
-1,392
| -3% | -$802K | 1.27% | 10 |
|
|
2022
Q4 | $29.9M | Sell |
54,215
-1,470
| -3% | -$810K | 1.7% | 8 |
|
|
2022
Q3 | $28.2M | Buy |
55,685
+943
| +2% | +$478K | 1.53% | 6 |
|
|
2022
Q2 | $29.7M | Sell |
54,742
-598
| -1% | -$325K | 1.52% | 5 |
|
|
2022
Q1 | $32.7M | Buy |
55,340
+859
| +2% | +$507K | 1.55% | 6 |
|
|
2021
Q4 | $36.4M | Buy |
+54,481
| New | +$36.4M | 2% | 4 |
|